South America

This book chapter advances SDG 3 and 10 by reviewing the health and mental health inequities of American Indian and Alaska Native (AI/AN) communities and how to overcome the disparities.
This book chapter advances SDG 3 and 10 by reviewing important considerations for working with Arab/Middle Eastern and North African (MENA) youth, including considerations of acculturation, discrimination, and cultural considerations regarding clinical care
This book chapter advances SDG 3 and 10 by providing an overview of the mechanisms and factors likely to influence mental health and access to care of ethnic minority older adults.
This book chapter advances SDG 3 and 10 by reviewing specific applications of CPT in diverse populations and across cultures. This chapter provides a clinicians with guidance in applying this approach to the patients they may see in their own settings in order that they can all apply CPT in the most culturally sensitive way.
This book chapter advances SDG 3 and 10 by describing and discussing (1) the existing evidence examining associations between mental health and technology use including depression, anxiety, body dissatisfaction, attention-deficit disorders (and risks of distraction), and addictive behaviors and (2) the impacts of risky online communities on adolescents’ mental health, focusing on networks promoting proeating disorder behaviors and prosuicidality.
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive decline in cognitive function. Intracerebroventricular injection of streptozotocin (icv-STZ) has been used as an experimental model of Sporadic AD (SAD) in rodents and represents a promising tool for etiopathogenic analysis and evaluation of new therapeutic proposals for AD. The icv-STZ model shows many aspects of SAD abnormalities, resulting in decreased brain glucose and energy metabolism, cognitive impairment, oxidative stress, neuronal loss, and amyloid angiopathy.
This book chapter advances SDG #3 and #10 by outlining how both the asymptomatic and symptomatic predementia phases of AD, amyloid positivity using amyloid PET imaging could predict progression to AD dementia. Amyloid PET imaging can identify the status of Aβ deposition in the underlying AD pathophysiology, increase diagnostic certainty, and alter management. This approach could improve the diagnose and management for patients with memory loss or cognitive dysfunction.
Elsevier,

Diagnosis and Management in Dementia: The Neuroscience of Dementia, Volume 1, Volume , 1 January 2020

This book chapter advances SDG #3 and #10 by focusing on providing a brief overview of genes associated with sporadic (late-onset) Alzheimer's disease (AD).
This book chapter advances SDG #3 and #10 by reviewing background on neurocognitive disorders, approaches to diagnosis, and management of several of the more problematic psychiatric complications of dementia. Disorders reviewed include AD, vascular dementia, Lewy body disease, and frontotemporal dementia. Psychiatric symptoms reviewed include apathy, agitation, psychosis, depression, and anxiety.
This book chapter advances SDG #3 and #10 by providing an overview of natural AChE inhibitors extracted from plants and their therapeutic potential to treat AD.

Pages